Bioptik Technology Incorporation (TPEX:4161)

Taiwan · Delayed Price · Currency is TWD

23.20

+0.10 (0.43%)

Jun 18, 2026, 1:30 PM CST

-15.43% (1Y)

Market Cap	1.39B -15.9%
Revenue (ttm)	865.76M +2.9%
Net Income	73.94M -18.1%
EPS	1.23 -19.4%
Shares Out	59.81M
PE Ratio	18.80
Forward PE	n/a
Dividend	0.70 (3.02%)
Ex-Dividend Date	n/a

Volume	69,981
Open	23.15
Previous Close	23.10
Day's Range	23.00 - 23.35
52-Week Range	22.60 - 30.50
Beta	0.25
Analysts	Buy
Price Target	41.91 (+80.65%)
Earnings Date	Aug 7, 2026

About TPEX:4161

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscree... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1999

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4161

Full Company Profile

Financial Performance

In 2025, TPEX:4161's revenue was 837.19 million, a decrease of -3.25% compared to the previous year's 865.34 million. Earnings were 71.19 million, a decrease of -23.92%.

Financial Statements